KFDA formulates a guideline for nomenclature of new drugs

Published: 2003-10-06 06:58:00

Updated: 2003-10-06 06:58:00

The Korea Food and Drug Administration has recently announced that as Korea is likely to create global new drugs within a couple of years, it formulated a guideline for unified nomenclature of new drugs including Korean nomenclature of imported items, as part of its efforts to avert any confusion...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK